Crossmark

Influence of levothyroxine replacement on metabolic dysfunction-associated steatotic liver disease and dyslipidemia in subclinical hypothyroidism: insights from a randomized controlled study

Crossref DOI link: https://doi.org/10.1186/s43162-025-00415-y

Published Online: 2025-02-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mahran, Zainab Gaber

Osman, Salma Mokhtar

Abdelmawgod, Amira

Makhlouf, Nahed A.

Hassan, Elham Ahmed

Moustafa, Ehab F.
Funding

Funding for this research was provided by:

Faculty of Medicine, Assiut University (2021-01-19-001, 2021-01-19-001, 2021-01-19-001, 2021-01-19-001, 2021-01-19-001, 2021-01-19-001)
License Information

Text and Data Mining valid from 2025-02-10

Version of Record valid from 2025-02-10
More Information

Article History

Received: 29 November 2024

Accepted: 1 February 2025

First Online: 10 February 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below